These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Solubility, absorption, and anti-Helicobacter pylori activity of bismuth subnitrate and colloidal bismuth subcitrate: In vitro data Do not predict In vivo efficacy. Phillips RH; Whitehead MW; Lacey S; Champion M; Thompson RP; Powell JJ Helicobacter; 2000 Sep; 5(3):176-82. PubMed ID: 10971684 [TBL] [Abstract][Full Text] [Related]
12. Distribution of bismuth in the rat after oral dosing with ranitidine bismuth citrate and bismuth subcitrate. Canena J; Reis J; Pinto AS; Santos AM; Leitão J; Pinheiro T; Quina MG J Pharm Pharmacol; 1998 Mar; 50(3):279-83. PubMed ID: 9600719 [TBL] [Abstract][Full Text] [Related]
13. One-week ranitidine bismuth citrate versus colloidal bismuth subcitrate-based anti-Helicobacter triple therapy: a prospective randomized controlled trial. Kung NN; Sung JJ; Yuen NW; Li TH; Ng PW; Lai WM; Lui YH; Lam KN; Choi CH; Leung EM Am J Gastroenterol; 1999 Mar; 94(3):721-4. PubMed ID: 10086657 [TBL] [Abstract][Full Text] [Related]
14. Absorption of bismuth from two bismuth compounds before and after healing of peptic ulcers. Hundal O; Bergseth M; Gharehnia B; Andersen KJ; Berstad A Hepatogastroenterology; 1999; 46(29):2882-6. PubMed ID: 10576366 [TBL] [Abstract][Full Text] [Related]
15. The effect of intracellular “depot” helicobacter pylori infection on the quality of eradication with monotheraphy of patients with chronic non-atrophic gastritis by the bismuth colloidal subcitrate. Avramenko AA Wiad Lek; 2019 Oct; 72(10):1909-1911. PubMed ID: 31982012 [TBL] [Abstract][Full Text] [Related]
16. Phospholipase activity of Helicobacter pylori and its inhibition by bismuth salts. Biochemical and biophysical studies. Ottlecz A; Romero JJ; Hazell SL; Graham DY; Lichtenberger LM Dig Dis Sci; 1993 Nov; 38(11):2071-80. PubMed ID: 8223083 [TBL] [Abstract][Full Text] [Related]
17. A potential mechanism of action of colloidal bismuth subcitrate: diffusion barrier to hydrochloric acid. Lee SP Scand J Gastroenterol Suppl; 1982; 80():17-21. PubMed ID: 6962540 [TBL] [Abstract][Full Text] [Related]
18. Short and long term outcome of Helicobacter pylori positive resistant duodenal ulcers treated with colloidal bismuth subcitrate plus antibiotics or sucralfate alone. Bianchi Porro G; Parente F; Lazzaroni M Gut; 1993 Apr; 34(4):466-9. PubMed ID: 8491391 [TBL] [Abstract][Full Text] [Related]
19. Structure of colloidal bismuth subcitrate (CBS) in dilute HCl: unique assembly of bismuth citrate dinuclear units ([Bi(cit)(2)Bi](2-)). Li W; Jin L; Zhu N; Hou X; Deng F; Sun H J Am Chem Soc; 2003 Oct; 125(41):12408-9. PubMed ID: 14531674 [TBL] [Abstract][Full Text] [Related]
20. Comparison of colloidal bismuth subcitrate and metronidazole, both in combination with an H2-antagonist as therapy for Helicobacter pylori. Baffone W; Belbusti F; Barbieri E; Pianetti A; Bruscolini F; Fabi MT; Salvaggio L; Albano A J Chemother; 1997 Jun; 9(3):208-12. PubMed ID: 9210004 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]